Vertex Pharmaceuticals initially wanted to charge £100,000 per patient per year for the drug PAA life-saving cystic fibrosis drug is to be made available on the NHS after a deal with a private health company. NHS England reached a deal with Vertex Pharmaceuticals, the drug’s manufacturer, after a row over the cost, which dragged on for more than three years. The company wanted to charge £100,000 per patient per year but a compromise was reached in a confidential deal. It is, according to the BBC, understood to involve significantly less than the sum originally asked for. Two other drugs made by Vertex — Symkevi and Kalydeco — will also be made…

Source: The Times October 24, 2019 23:03 UTC